News | Heart Valve Technology | August 05, 2016

CMS Changes MitraClip Reimbursement Codes to Widen Patient Access

mitraclip, mitraclip reimbursement

August 5, 2016 — The Centers for Medicare and Medicaid Services (CMS) has reassigned MitraClip transcatheter mitral valve repair procedures to the diagnosis-related group (DRG) codes 228-229 for “Other Cardiothoracic Procedures, with and without major complications or comorbidities (MCCs)." The change is expected to boost reimbursement and allow more Medicare patients to have access to the technology. 

“We commend CMS for this final step to ensure adequate reimbursement for MitraClip,” Abbott said in a statement.  “With this rule, CMS has opened the door for Medicare patients who may benefit from MitraClip to have broader access to the device. We appreciate CMS’s proactive approach in recognition of the substantial benefits of this therapy — from issuing a National Coverage Determination, New Technology Add-on Payment approval, physician reimbursement and now MS-DRG reassignment that will make hospital MitraClip programs sustainable.”

Abbott said the changes demonstrate the government’s commitment to provide access to innovation for seniors and others in the Medicare program.
 
MitraClip is the only FDA-cleared treatment of its kind for percutaneous mitral valve repair. It is a performed as a beating-heart procedure with no cardiopulmonary bypass required. It allows for real-time positioning and repositioning to optimize mitral regurgitation reduction, and is designed to preserve surgical options.

The ruling can be viewed at www.federalregister.gov/public-inspection.

Watch the video "Transcatheter Mitral Valve Repair Technologies."

 

Related Content

Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
News | Peripheral Artery Disease (PAD)| September 13, 2017
A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results of PQ Bypass’ Detour...
Overlay Init